Skip to main content
Clinical Trials/NCT06384105
NCT06384105
Recruiting
Not Applicable

Prospective Multicentric Study of the Patient Radiation Dose During Five Endourological Procedures: Insertion and Replacement of Ureteral Stent, URS, (Mini-)PCNL/ PCNL and ESWL/SWL

Universiteit Antwerpen2 sites in 1 country870 target enrollmentDecember 19, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Radiation Exposure
Sponsor
Universiteit Antwerpen
Enrollment
870
Locations
2
Primary Endpoint
Dose limit
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

In the medical world more and more procedures are performed with the use of ionizing radiation (x-ray), both diagnostic and therapeutic. The main and most known risk is the development of malignancies as a result of the use of ionizing radiation.

Purpose of this study: To examine the patient radiation dose (PRD) if the frames per second (FPS) are set differently during the five most performed endourological procedures where fluoroscopy is used (insertion/replacement of ureteral stent, (mini-)percutaneous nephrolithotomy (PCNL/PNL), ureterorenoscopy (URS) and extracorporeal shock wave lithotripsy (ESWL/SWL)) and to propose an acceptable PRD for these procedures in a multicentric study.

Registry
clinicaltrials.gov
Start Date
December 19, 2023
End Date
December 18, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Vincent De Coninck

Principal Investigator

Universiteit Antwerpen

Eligibility Criteria

Inclusion Criteria

  • all patients who receive insertion/replacement of ureteral stent, URS (flexible or semirigid), (mini-)PCNL (including ECIRS) or ESWL under fluoroscopic with or without ultrasonic guidance
  • Only cases performed or directly supervised by experts

Exclusion Criteria

  • Bilateral cases
  • Diagnostic ureterorenoscopies
  • Antegrade ureteroscopies
  • Procedures for Upper Tract Urothelial Carcinoma (UTUC)
  • Procedures on children (aged \<18 years)
  • Pregnant women
  • Abnormal urinary anatomy (e.g. ureteral duplication, pelvic kidney, bladder derivation, horseshoe kidney)

Outcomes

Primary Outcomes

Dose limit

Time Frame: 1 year

Dose limit for the PRD during the insertion or replacement of a ureteral stent, URS, PCNL and ESWL

Secondary Outcomes

  • Difference in PRD(1 year)
  • PRD different centres(1 year)
  • PRD difference complicated cases(1 year)

Study Sites (2)

Loading locations...

Similar Trials